Granville Capital’s Merck MRK Stock Holding History

Granville Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$291K	Sell	2,423 -210	-8%	-$24.2K	0.15%	58
2025 Q4	$277K	Buy	+2,633	New	+$247K	0.15%	66

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Granville Capital's MRK Position: Q1 2026 in Review

Granville Capital reduced its Merck (MRK) stake by 8% in Q1 2026, selling an estimated $24.2K and leaving 2,423 shares worth $291K. The position accounts for 0.15% of the portfolio, ranked #58.

Granville Capital first reported a position in MRK in Q4 2025 and has held it in 2 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Granville Capital held 2,423 shares of Merck worth $291K as of Q1 2026.
Granville Capital sold 210 Merck shares in Q1 2026, an estimated $24.2K.
Merck made up 0.15% of Granville Capital's portfolio in Q1 2026, its #58 holding.
Granville Capital first reported a position in Merck in Q4 2025 and has held it in 2 quarters since.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Granville Capital's 13F filing for Q1 2026, filed 11 May 2026.